News | October 09, 2023
Thermo Fisher Scientific expands St. Louis manufacturing for complex biologic treatments
Increased capability to produce medicines for challenging diseases including cancer
Increased capability to produce medicines for challenging diseases including cancer
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Lokavant provides clinical trial intelligence
Advances Amgen's mission to serve patients with rare disease medicines
WINLEVI works differently from any other topical acne treatment
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
The companies will work with investigators to share the results with the scientific community
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Subscribe To Our Newsletter & Stay Updated
